A bill to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, and for other purposes.

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2026-04-30

The proposal would extend a program designed to speed up approval and access to treatments for ALS (amyotrophic lateral sclerosis, also known as Lou Gehrig's disease) through 2031, allowing the government to continue supporting faster development and availability of therapies for patients with this serious neurological condition. The extension would help maintain streamlined pathways that allow drug companies and researchers to bring new ALS treatments to patients more quickly than the standard approval process.